It would therefore be useful to also examine the anti-metastatic potential of opaganib in a NB tumor model that allows tumor migration, such as that described by Seong et al., in which the dual SK1/SK2 inhibitor SKI-II suppressed NB cell migration in vivo [109]. The gene discussed is SPHK2; the disease is neoplasm.